FDA Panel Recommends Johnson & Johnson COVID Booster Shot

In Summary

The Johnson & Johnson company has said the additional dose adds more protection against COVID-19.

The U.S. Food and Drug Administration panel on Friday endorsed a booster shot of the Johnson & Johnson COVID-19 vaccine, according to the Associated Press.  

The panel cited concerns that Americans who got one shot are not as protected as those who received two shots. Additionally, J&J said the additional dose adds more protection against the deadly coronavirus.  

RELATED: Johnson & Johnson: Booster Shot Causes Nine-Fold Increase in Antibodies

According to AP, the FDA’s panel voted unanimously in support of the booster being given two months after immunization. A number of experts believe it makes sense to think of the J&J vaccine as a two-dose vaccine. 

“I think this frankly was always a two-dose vaccine,” said FDA adviser Dr. Paul Offit. “It would be hard to recommend this as a single-dose vaccine at this point.” 

RELATED: FDA Panel Votes Against COVID-19 Booster Shot

According to the CDC, the J&J, Pfizer and Moderna vaccines have been shown to protect against death and hospitalizations that can occur from COVID-19. The primary goal is to give the first shots to those who haven’t been vaccinated, as 66% of Americans have received a vaccine, according to The New York Times

What makes this situation more urgent is that in several studies J&J’s vaccine has shown lower effectiveness, AP reported. Also, there have been reported breakthrough infections involving those who are fully vaccinated because of the delta variant. 

RELATED: CDC: US should resume use of Johnson & Johnson COVID-19 vaccine

“This is really — with the second dose — bringing it, I think, on par with those other vaccines in terms of effectiveness,” Dr. Archana Chatterjee of Rosalind Franklin University told AP. 

Latest in Coronavirus Pandemic

Coronavirus Pandemic

NYC Places Vaccine Mandate on Private Sector Employers

Omicron Variant Cases

Coronavirus Pandemic

China Offers 600 Million COVID-19 Vaccine Doses to Africa

Coronavirus Pandemic

First US Case of COVID-19 Omicron Variant Detected in California

Omicron Variant Cases

Coronavirus Pandemic

Omicron COVID-19 Variant Found in Europe Before Reaching South Africa

Coronavirus Pandemic

President Biden Announces Travel Ban in Response to Omicron COVID-19 Variant

Coronavirus Pandemic

Britain Reviewing Racial Bias in Pulse Oximeters Related to COVID Deaths

Coronavirus Pandemic

Moderna and Pfizer’s COVID Vaccine Booster Shots Cleared by FDA

Coronavirus Pandemic

Unvaxxed Aaron Rodgers and Kyrie Irving: What Is the Difference?